Report Detail
Global Vaccine for Influenza Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4666396 |
- 22 January, 2026 |
- Global |
- 107 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Vaccine for Influenza market size was valued at US$ 9674 million in 2025 and is forecast to a readjusted size of US$ 13930 million by 2032 with a CAGR of 5.4% during review period.
The Influenza Vaccine is a biological product designed to stimulate the human immune system to produce virus-specific antibodies, thereby preventing seasonal influenza infection and reducing the risks of severe illness, complications, and mortality. Its mechanism relies on inactivated, attenuated, recombinant, or genetically engineered antigen delivery technologies that safely induce protective immune memory. As one of the most strategic public-health tools worldwide, influenza vaccines are incorporated into national immunization programs or prioritized recommendations by health authorities to lower disease burden, reduce healthcare utilization, and protect high-risk populations such as the elderly, patients with chronic conditions, pregnant women, and children. With continuous viral mutation and strengthened global surveillance, influenza vaccines are undergoing ongoing innovation in formulation updates, platform technologies, strain-matching optimization, and production efficiency, thereby supporting population health, medical cost containment, and sustainable industry growth.In 2024, global Vaccine for Influenza production reached approximately 845.8 m units, with an average global market price of around US$ 10.8 perunit.The average gross profit margin of this product is 56%.
The strengthening of global public-health systems is transforming influenza vaccines from “seasonal demand products” into “fundamental health-protection tools.” Governments are increasing investment in preventive medicine, expanding immunization coverage, and enhancing protection for key populations, creating stable demand momentum. Annual reports of major vaccine companies highlight continuous upgrades in mRNA, recombinant protein, and adjuvant-enhanced platforms, improving antigenicity, production speed, and strain-matching accuracy. Regulatory reforms in approval pathways, manufacturing upgrades, and international harmonization are enhancing supply-chain resilience. As enterprises, healthcare institutions, and insurers increasingly recognize the economic impact of influenza peaks, vaccines are positioned as the most cost-effective preventive solution, supporting long-term growth.
The industry faces uncertainties due to continuous viral mutation, requiring ongoing strain adaptation and formulation updates that increase R&D and manufacturing pressure. In some countries, limited public awareness or high out-of-pocket vaccination costs lead to fluctuating uptake rates. The reliance on specific upstream materials and specialized manufacturing equipment means that global logistics, regulatory adjustments, or regional policy changes can impact capacity deployment. Annual reports also indicate intensified competition, with novel technology platforms entering rapidly, forcing traditional manufacturers to invest heavily in R&D and production upgrades. Differing cold-chain standards across countries add further complexity to cross-border distribution.
Demand is shifting from “seasonal vaccination” to “routine immunization management,” particularly among high-risk groups such as the elderly, respiratory-disease patients, and healthcare workers. Hospitals, schools, and large enterprises increasingly adopt centralized procurement to mitigate the operational impact during influenza peaks. With rising consumer awareness, quadrivalent vaccines, high-immunogenicity formulations, preservative-free products, and next-generation platforms are seeing faster penetration. Expanded deployment of community clinics, pharmacies, and mobile vaccination points is improving accessibility. Corporate and insurance-driven population-health programs are also steering demand toward higher-quality vaccines.
Key upstream inputs include seed viruses, cell substrates, specialized culture media, adjuvant systems, and sterile-filling consumables, with global suppliers relatively concentrated. Annual reports show that advanced platforms require higher purity, stability, and consistency in antigen and adjuvant materials, increasing the technological intensity and quality sensitivity of the supply chain. As egg-based, cell-based, and recombinant systems evolve in parallel, differences in raw materials have a direct impact on process efficiency and capacity scalability. Requirements for cold-chain packaging, quality-control reagents, and testing consumables are also rising, pushing the upstream ecosystem toward higher standards and broader internationalization.
This report is a detailed and comprehensive analysis for global Vaccine for Influenza market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccine for Influenza market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Vaccine for Influenza market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Vaccine for Influenza market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Vaccine for Influenza market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine for Influenza
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine for Influenza market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccine for Influenza market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Technology
Chicken Embryo Technology
Cell Culture Technology
Recombinant Technology
Adjuvant Vaccines
Market segment by Administration
Injectable
Nasal Spray
Market segment by Application
6 Months to 3 Years
> 3 Years
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine for Influenza product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine for Influenza, with price, sales quantity, revenue, and global market share of Vaccine for Influenza from 2021 to 2026.
Chapter 3, the Vaccine for Influenza competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Influenza breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Vaccine for Influenza market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine for Influenza.
Chapter 14 and 15, to describe Vaccine for Influenza sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Vaccine for Influenza Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Trivalent Influenza Vaccine
- 1.3.3 Quadrivalent Influenza Vaccine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Vaccine for Influenza Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 6 Months to 3 Years
- 1.4.3 > 3 Years
- 1.5 Global Vaccine for Influenza Market Size & Forecast
- 1.5.1 Global Vaccine for Influenza Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Vaccine for Influenza Sales Quantity (2021-2032)
- 1.5.3 Global Vaccine for Influenza Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Vaccine for Influenza Product and Services
- 2.1.4 Sanofi Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sanofi Recent Developments/Updates
- 2.2 CSL
- 2.2.1 CSL Details
- 2.2.2 CSL Major Business
- 2.2.3 CSL Vaccine for Influenza Product and Services
- 2.2.4 CSL Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 CSL Recent Developments/Updates
- 2.3 GSK
- 2.3.1 GSK Details
- 2.3.2 GSK Major Business
- 2.3.3 GSK Vaccine for Influenza Product and Services
- 2.3.4 GSK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 GSK Recent Developments/Updates
- 2.4 Viatris
- 2.4.1 Viatris Details
- 2.4.2 Viatris Major Business
- 2.4.3 Viatris Vaccine for Influenza Product and Services
- 2.4.4 Viatris Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Viatris Recent Developments/Updates
- 2.5 AstraZeneca
- 2.5.1 AstraZeneca Details
- 2.5.2 AstraZeneca Major Business
- 2.5.3 AstraZeneca Vaccine for Influenza Product and Services
- 2.5.4 AstraZeneca Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 AstraZeneca Recent Developments/Updates
- 2.6 Hualan Bio
- 2.6.1 Hualan Bio Details
- 2.6.2 Hualan Bio Major Business
- 2.6.3 Hualan Bio Vaccine for Influenza Product and Services
- 2.6.4 Hualan Bio Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Hualan Bio Recent Developments/Updates
- 2.7 Changchun Institute of Biological
- 2.7.1 Changchun Institute of Biological Details
- 2.7.2 Changchun Institute of Biological Major Business
- 2.7.3 Changchun Institute of Biological Vaccine for Influenza Product and Services
- 2.7.4 Changchun Institute of Biological Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Changchun Institute of Biological Recent Developments/Updates
- 2.8 Sinovac
- 2.8.1 Sinovac Details
- 2.8.2 Sinovac Major Business
- 2.8.3 Sinovac Vaccine for Influenza Product and Services
- 2.8.4 Sinovac Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Sinovac Recent Developments/Updates
- 2.9 BCHT
- 2.9.1 BCHT Details
- 2.9.2 BCHT Major Business
- 2.9.3 BCHT Vaccine for Influenza Product and Services
- 2.9.4 BCHT Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 BCHT Recent Developments/Updates
- 2.10 Jiangsu GDK
- 2.10.1 Jiangsu GDK Details
- 2.10.2 Jiangsu GDK Major Business
- 2.10.3 Jiangsu GDK Vaccine for Influenza Product and Services
- 2.10.4 Jiangsu GDK Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Jiangsu GDK Recent Developments/Updates
- 2.11 KM Biologics
- 2.11.1 KM Biologics Details
- 2.11.2 KM Biologics Major Business
- 2.11.3 KM Biologics Vaccine for Influenza Product and Services
- 2.11.4 KM Biologics Vaccine for Influenza Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 KM Biologics Recent Developments/Updates
3 Competitive Environment: Vaccine for Influenza by Manufacturer
- 3.1 Global Vaccine for Influenza Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Vaccine for Influenza Revenue by Manufacturer (2021-2026)
- 3.3 Global Vaccine for Influenza Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Vaccine for Influenza by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Vaccine for Influenza Manufacturer Market Share in 2025
- 3.4.3 Top 6 Vaccine for Influenza Manufacturer Market Share in 2025
- 3.5 Vaccine for Influenza Market: Overall Company Footprint Analysis
- 3.5.1 Vaccine for Influenza Market: Region Footprint
- 3.5.2 Vaccine for Influenza Market: Company Product Type Footprint
- 3.5.3 Vaccine for Influenza Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Vaccine for Influenza Market Size by Region
- 4.1.1 Global Vaccine for Influenza Sales Quantity by Region (2021-2032)
- 4.1.2 Global Vaccine for Influenza Consumption Value by Region (2021-2032)
- 4.1.3 Global Vaccine for Influenza Average Price by Region (2021-2032)
- 4.2 North America Vaccine for Influenza Consumption Value (2021-2032)
- 4.3 Europe Vaccine for Influenza Consumption Value (2021-2032)
- 4.4 Asia-Pacific Vaccine for Influenza Consumption Value (2021-2032)
- 4.5 South America Vaccine for Influenza Consumption Value (2021-2032)
- 4.6 Middle East & Africa Vaccine for Influenza Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 5.2 Global Vaccine for Influenza Consumption Value by Type (2021-2032)
- 5.3 Global Vaccine for Influenza Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 6.2 Global Vaccine for Influenza Consumption Value by Application (2021-2032)
- 6.3 Global Vaccine for Influenza Average Price by Application (2021-2032)
7 North America
- 7.1 North America Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 7.2 North America Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 7.3 North America Vaccine for Influenza Market Size by Country
- 7.3.1 North America Vaccine for Influenza Sales Quantity by Country (2021-2032)
- 7.3.2 North America Vaccine for Influenza Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 8.2 Europe Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 8.3 Europe Vaccine for Influenza Market Size by Country
- 8.3.1 Europe Vaccine for Influenza Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Vaccine for Influenza Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Vaccine for Influenza Market Size by Region
- 9.3.1 Asia-Pacific Vaccine for Influenza Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Vaccine for Influenza Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 10.2 South America Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 10.3 South America Vaccine for Influenza Market Size by Country
- 10.3.1 South America Vaccine for Influenza Sales Quantity by Country (2021-2032)
- 10.3.2 South America Vaccine for Influenza Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Vaccine for Influenza Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Vaccine for Influenza Market Size by Country
- 11.3.1 Middle East & Africa Vaccine for Influenza Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Vaccine for Influenza Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Vaccine for Influenza Market Drivers
- 12.2 Vaccine for Influenza Market Restraints
- 12.3 Vaccine for Influenza Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Vaccine for Influenza and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Vaccine for Influenza
- 13.3 Vaccine for Influenza Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Vaccine for Influenza Typical Distributors
- 14.3 Vaccine for Influenza Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Vaccine for Influenza. Industry analysis & Market Report on Vaccine for Influenza is a syndicated market report, published as Global Vaccine for Influenza Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Vaccine for Influenza market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
